文献速递糖尿病

连续血糖监测指标可预测糖尿病患者全因死亡率:一项真实世界长期研究

Continuous Glucose Monitoring Metrics Predict All-Cause Mortality in Diabetes: A Real-world Long-term Study.
PubMed 文献 · Diabetes Care · 2025-01-01

该研究基于美国退伍军人医疗系统2752例接受Dexcom CGM的成人糖尿病患者(65%为T2D),分析CGM衍生指标与5年全因死亡率的关联。结果显示,平均血糖、高于目标范围时间、血糖变异系数和血糖风险指数升高及目标范围内时间降低均与死亡率相关,且独立于HbA1c。

要点

  • CGM指标(MG、TAR、CV、GRI、TIR)与5年全因死亡率显著相关。
  • 上述关联在调整HbA1c后仍显著,提示CGM指标可补充HbA1c评估长期风险。
  • CV与死亡率的关联独立于其他CGM指标,在HbA1c较低者中似最强。

核心结论

  • CGM衍生指标与糖尿病患者全因死亡率相关,可能比HbA1c更好地反映血糖波动及高低血糖时段的长期风险。

研究设计与样本

  • 回顾性队列研究,纳入2752例≥21岁接受Dexcom CGM的糖尿病成人(65%为T2D),CGM使用中位近3年,随访5年评估全因死亡率。

主要发现

  • 共发生407例死亡。
  • 6个月标志期分析中,平均血糖、TAR、CV、GRI升高及TIR降低与5年死亡率相关(HR分别为1.18、1.20、1.18、1.23、0.83;均P≤0.01)。
  • 上述关联在调整标志期HbA1c后仍显著,缩短CGM观察窗口结果相似。
  • CV与死亡率的关联独立于其他CGM指标,且在HbA1c较低者中似最强。

临床怎么用

  • 临床解读CGM报告时,除TIR外应关注MG、TAR、CV和GRI,以更全面评估长期死亡风险。
  • 对于HbA1c较低但血糖波动大的患者,CV可能提示额外风险,需加强管理。

局限性

  • 研究为观察性设计,无法确立因果关系。
  • 人群以退伍军人为主,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Investigate the association between continuous glucose monitoring (CGM)-derived glucose metrics and all-cause mortality in patients with type 1 or type 2 diabetes (T1D or T2D). RESEARCH DESIGN AND METHODS: We analyzed data from 2,752 adults (≥21 years old) with diabetes (65% T2D) from the Veterans Affairs Healthcare System who received Dexcom CGM between 2015 and 2020. All participants had ≥10 days of CGM data over landmark (LM) periods (14 days, 3 months, and 6 months) merged with electronic health records. All-cause mortality was assessed over 5 years from CGM initiation. Cox models evaluated associations between mortality and CGM metrics: mean glucose (MG, mg/dL), time in range (TIR, %), time above range (TAR, %), coefficient of variation (CV), and glycemic risk index (GRI, %). RESULTS: Mean age at CGM initiation was 64 years, and median CGM use was nearly 3 years. There were 407 deaths. In separate multivariable Cox models (adjusting for mortality-related variables), higher MG, TAR, CV, and GRI and lower TIR during the 6-month LM were associated with 5-year mortality (hazard ratios: MG 1.18, TAR 1.20, GRI 1.23, CV 1.18, and TIR 0.83; all P ≤ 0.01) and those associations remained significant after adjusting for LM HbA1c. Results were similar with shorter CGM LM observation windows. The association between CV and mortality was independent of other CGM metrics and appeared strongest in those with lower HbA1c levels. CONCLUSIONS: CGM-derived metrics were associated with all-cause mortality in patients with diabetes and may better capture long-term risk associated with glucose fluctuations and periods of hypo- and hyperglycemia than HbA1c.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Okuno T, Macwan SA, Norman GJ, et al. Continuous Glucose Monitoring Metrics Predict All-Cause Mortality in Diabetes: A Real-world Long-term Study. Diabetes Care. 2025. PMID: 40768053. doi:10.2337/dc25-0716

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。